转移瘤体积对脑转移瘤放射治疗的预后影响(4)
[9]朱虹，呂博，李云海，等. 脑转移瘤放射治疗的预后因素分析及预后模型的建立[J].中国癌症杂志，2014，(6)：457-462.
[10]Rases D，Bartscht T，Schild SE. Predictors of survival in patients with brain metastases from gastric cancer[J]. Neoplasma，2017，64(1)：136-139.
[11]Kim IK，Starke RM，Mcrae DA，et al. Cumulative volumetric analysis as a key criterion for the treatment of brain metastases[J]. J Clin Neurosci，2017，(5)：142-146.
[12]Suzuki S，Inoue T，Ishido K. Factors influencing local tumor control after Gamma Knife radiosurgery for intracranial metastases from breast cancet[J].J Clin Neurosci，2016，(11)：154-158.
[13]Aoki S，Kanda T，Matsutani N，et al. Examination of the predictive factors of the response to whole brain radiotherapy for brain metastases from lung cancer using MRI[J].Oncol Lett，2017，14(1)：1073-1079.
[14]Rades D，Panzner A，Dziggel L，et al. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis[J]. Cancer，2012，118(15)：3852-3859.
[15]Sperduto PW，Shanley R，Lou X，et al. Secondary analysis of RTOG 9508，a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases； poststratified by the graded prognostic assessment (GPA) [J]. International Journal of Radiation Oncology，Biology，Physics，2014，90(3)：526-531.
(收稿日期：2017-07-03), 百拇医药(林贵山 黄俊鹏 陈静波 蒋桂成)
[10]Rases D，Bartscht T，Schild SE. Predictors of survival in patients with brain metastases from gastric cancer[J]. Neoplasma，2017，64(1)：136-139.
[11]Kim IK，Starke RM，Mcrae DA，et al. Cumulative volumetric analysis as a key criterion for the treatment of brain metastases[J]. J Clin Neurosci，2017，(5)：142-146.
[12]Suzuki S，Inoue T，Ishido K. Factors influencing local tumor control after Gamma Knife radiosurgery for intracranial metastases from breast cancet[J].J Clin Neurosci，2016，(11)：154-158.
[13]Aoki S，Kanda T，Matsutani N，et al. Examination of the predictive factors of the response to whole brain radiotherapy for brain metastases from lung cancer using MRI[J].Oncol Lett，2017，14(1)：1073-1079.
[14]Rades D，Panzner A，Dziggel L，et al. Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis[J]. Cancer，2012，118(15)：3852-3859.
[15]Sperduto PW，Shanley R，Lou X，et al. Secondary analysis of RTOG 9508，a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases； poststratified by the graded prognostic assessment (GPA) [J]. International Journal of Radiation Oncology，Biology，Physics，2014，90(3)：526-531.
(收稿日期：2017-07-03), 百拇医药(林贵山 黄俊鹏 陈静波 蒋桂成)